Filing Details
- Accession Number:
- 0001415889-21-002667
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-25 15:45:25
- Reporting Period:
- 2021-05-21
- Accepted Time:
- 2021-05-25 15:45:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1411906 | Ampio Pharmaceuticals Inc. | AMPE | Pharmaceutical Preparations (2834) | 260179592 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1717673 | Holli Cherevka | C/O Ampio Pharmaceuticals, Inc. 373 Inverness Parkway, Suite 200 Englewood CO 80112 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-21 | 2,603 | $0.51 | 2,603 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-05-21 | 2,603 | $2.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-05-21 | 2,603 | $0.00 | 2,603 | $0.51 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 152,766 | 2029-09-16 | No | 4 | M | Direct |
Footnotes
- The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 12, 2021.
- Options were granted and previously reported on a Form 4 filed on September 18, 2019, where 50% of the options awarded vested and became exercisable on the grant date of September 16, 2019 and the other 50% of the options awarded vested and became exercisable on the first anniversary of the grant date.
Billionaire Hedge Funds
